US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Integrated Ventures, Inc.

0.3410

0.0000

Volume:- -

Turnover:- -

Market Cap:2.09M

PE:-0.53

High:0.3410

Open:0.3410

Low:0.3410

Close:0.3410

52wk High:0.3508

52wk Low:0.2000

Shares:6.14M

Float Shares:3.27M

Volume Ratio:0.00

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6408

EPS(LYR):-83.9311

ROE:-698.85%

ROA:-54.64%

PB:-0.38

PE(LYR):0.00

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Press Release: Transgene's Individualized Neoantigen Therapeutic Cancer Vaccine TG4050 Delivers Positive Randomized Phase I Data Randomization to be Completed in Phase II Part in Q4 2025

MedWellAI Inc. Announces Share Exchange Agreement with BHP Capital NY, Inc

Integrated Ventures Inc. Delays Q1 2025 Financial Report Amid Revenue Decline

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INTV"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INTV\",,,,,undefined,":{"symbol":"INTV","market":"US","secType":"STK","nameCN":"Integrated Ventures, Inc.","latestPrice":0.341,"timestamp":1771621200000,"preClose":0.341,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":3274379,"shares":6136600,"eps":-0.640779,"marketStatus":"Market Closed","change":0,"latestTime":"02-20 16:00:00 EST Delay","open":0.341,"high":0.341,"low":0.341,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.640779,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.341,"volumeRatio":0.0007110015877945258},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INTV\",,,,,undefined,":{"symbol":"INTV","floatShares":3274379,"roa":"-54.64%","roe":"-698.85%","lyrEps":-83.931125,"volumeRatio":0.0007110015877945258,"shares":6136600,"dividePrice":0,"high":0.341,"amplitude":0,"preClose":0.341,"low":0.341,"week52Low":0.2,"pbRate":"-0.38","psRate":"1.38","week52High":0.3508,"institutionHeld":0,"latestPrice":0.341,"eps":-0.640779,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.640779,"open":0.341,"prevYearClose":0.341,"prevWeekClose":0.341,"prevMonthClose":0.341,"prevQuarterClose":0.341,"fiveDayClose":0.341,"twentyDayClose":0.341,"sixtyDayClose":0.341},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INTV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-15","symbol":"INTV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731646800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-09-30","symbol":"INTV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1727668800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-15","symbol":"INTV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-09","symbol":"INTV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707454800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-14","symbol":"INTV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INTV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INTV\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2567481919","title":"Press Release: Transgene's Individualized Neoantigen Therapeutic Cancer Vaccine TG4050 Delivers Positive Randomized Phase I Data Randomization to be Completed in Phase II Part in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2567481919","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567481919?lang=en_us&edition=fundamental","pubTime":"2025-09-16 23:45","pubTimestamp":1758037500,"startTime":"0","endTime":"0","summary":"Positive Phase I data with TG4050 in operable Head and Neck Squamous Cell Carcinoma . -- 100% disease-free survival after 2 years of follow-up -- data presented. -- Transgene to report additional immunological data at a scientific. Ongoing Phase II part with TG4050 in operable HNSCC. Preparing new Phase I trial in an additional indication. Transgene presented positive data from the randomized Phase I part of the ongoing multicenter Phase I/II trial  in an oral presentation at the American Society of Clinical Oncology  Annual Meeting . TG4050 was administered as a single agent in the adjuvant treatment of HPV-negative operable head and neck squamous cell carcinoma .principle. TG4050 also induced durable and specific T cell responses","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4160","LU1066053197.SGD","LU0106831901.USD","LU2360107671.USD","BK4588","BK4585","LU1668664300.SGD","LU1066051225.USD","BK4023","BK4022","LU1861217088.USD","INTV","LU1861220207.SGD","DFS","BK4166","LU1066051498.USD","LU1066051811.HKD","R","CTO","LU1791807156.HKD"],"gpt_icon":0},{"id":"2557914845","title":"MedWellAI Inc. Announces Share Exchange Agreement with BHP Capital NY, Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2557914845","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557914845?lang=en_us&edition=fundamental","pubTime":"2025-08-08 05:02","pubTimestamp":1754600522,"startTime":"0","endTime":"0","summary":"MedWellAI Inc., a Nevada corporation formerly known as Integrated Ventures, Inc., has announced a share exchange agreement with BHP Capital NY, Inc. As part of the agreement, MedWellAI Inc. aims to consolidate its Series C and Series D Preferred Stock classes. Consequently, BHP Capital NY will exchange its 3,000 shares of Series D Preferred Stock and 1,500 shares of Series C Preferred Stock for a total of 6,500 shares of Series C Preferred Stock. The transaction is effective as of July 21, 2025, with the agreement signed by Steve Rubakh, CEO of MedWellAI Inc., and Bryan Pantofel, President of BHP Capital NY, Inc.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MedWellAI Inc. published the original content used to generate this news brie","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nNDL34Hyh5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MWAI","BK4023","INTV"],"gpt_icon":0},{"id":"2535474876","title":"Integrated Ventures Inc. Delays Q1 2025 Financial Report Amid Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2535474876","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535474876?lang=en_us&edition=fundamental","pubTime":"2025-05-16 01:03","pubTimestamp":1747328626,"startTime":"0","endTime":"0","summary":"Integrated Ventures Inc. has announced a delay in filing its financial report for the period ended March 31, 2025. The report, which is a Form 10-Q, could not be filed on time due to reasons that could not be eliminated without unreasonable effort or expense. The company anticipates a significant change in its results of operations, including a decrease in digital assets mining revenue to $0 for the period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integrated Ventures Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2025, and is solely responsible for the information cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDLzw5Vn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTV"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/INTV\",params:#limit:6,delay:false,,,undefined,":[]}}